Cargando…
Liposome encapsulated Disulfiram inhibits NFκB pathway and targets breast cancer stem cells in vitro and in vivo
Breast cancer stem cells (BCSCs) are pan-resistant to different anticancer agents and responsible for cancer relapse. Disulfiram (DS), an antialcoholism drug, targets CSCs and reverses pan-chemoresistance. The anticancer application of DS is limited by its very short half-life in the bloodstream. Th...
Autores principales: | Liu, Peng, Wang, Zhipeng, Brown, Sarah, Kannappan, Vinodh, Tawari, Patricia Erebi, Jiang, Wenguo, Irache, Juan M., Tang, James Z., Britland, Stephen, Armesilla, Angel L., Darling, John L., Tang, Xing, Wang, Weiguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202137/ https://www.ncbi.nlm.nih.gov/pubmed/25277186 |
Ejemplares similares
-
The cytotoxic mechanisms of disulfiram and copper(ii) in cancer cells
por: Tawari, Patricia Erebi, et al.
Publicado: (2015) -
Poly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cells
por: Wang, Zhipeng, et al.
Publicado: (2017) -
Development of Injectable PEGylated Liposome Encapsulating Disulfiram for Colorectal Cancer Treatment
por: Najlah, Mohammad, et al.
Publicado: (2019) -
Investigation of the key chemical structures involved in the anticancer activity of disulfiram in A549 non-small cell lung cancer cell line
por: Butcher, Kate, et al.
Publicado: (2018) -
Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties
por: Yip, N C, et al.
Publicado: (2011)